Vitamin D Deficiency and Replacement on Pulmonary and Endocrine Function in SCI
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Studies have shown that individuals who have suffered a spinal cord injury are at an
increased risk of Vitamin D deficiency compared to able-bodied individuals. It has recently
been shown that Vitamin D deficiency is linked to a large number of diseases and conditions,
including chronic lung disease, vascular problems, and insulin resistance. If this common
nutritional deficiency is proven to be the cause of some of these diseases and conditions in
persons with SCI, then it may easily be remedied with a cheap and effective therapeutic
approach: vitamin D replacement therapy. Because of the high prevalence of vitamin D
deficiency in persons with SCI, this therapy alone or in combination with other treatment
options will be expected to significantly improve overall well being in the SCI population,
decrease hospitalization rate, and the lower the financial burden of care.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
James J. Peters Veterans Affairs Medical Center
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins